Glucagon-like peptide-1 is an incretin hormone known for its ability to lower your blood sugar levels, especially after eating and during fasting, by acting on organs like your pancreas and brain
It is about identifying the treatment approach a patient can realistically tolerate, maintain, and integrate into long-term health management
Cardiometabolic Comorbidity Research Because retatrutide modulates body weight, glycemia, and hepatic lipid endpoints simultaneously, it serves as a multi-axis probe in cardiometabolic research
If you want a broader overview of the treatment path, the article on how to get a GLP-1 medication for weight loss is a helpful companion
MORE VIDEOS IN Obesity What is a GLP-1
PMID: 16529340 DOI: 10.1331/154434506775268698 Tushuizen ME et al (2006): Incretin mimetics as a novel therapeutic option for hepatic steatosis